Call for Abstracts | CHIC Symposium 2024

HPV vaccination in LMICs of Southeast Asia and West Pacific Region Symposium 2024

We are thrilled to announce that following the success of last year symposiums focused on Francophone Africa, the Coalition to Strengthen the HPV Immunization Community (CHIC) is expanding its horizons to Southeast and West Pacific Region.

Continuing our commitment to fostering a community of practice for HPV vaccination programs, we are organizing an in-person symposium in Manila, Philippines, on the 2nd, 3rd, and 4th of October, 2024. This symposium, themed “HPV vaccination in LMICs of Southeast Asia and West Pacific Region: cross-country learning and lessons learned from sustainable HPV vaccination programs,” will focus on key aspects of HPV vaccination implementation and facilitate cross-country exchange in strategies to ensure comprehensive understanding of best-practices and common challenges.

Once again, we are extending an open invitation for the ‘Call for Abstracts,’ encouraging mid-career researchers and implementers from the region to contribute their expertise, findings, and experiences.

Join us in this transformative dialogue and be a part of the collective effort to advance HPV vaccination and cervical cancer elimination.

Abstract submission guidelines 

  • Priority will be given to the abstracts from within the region
  • Abstracts should represent the original work or a project where the author was actively involved 
  • Informative abstracts and critical abstracts are accepted
  • The Abstract should be written in English
  • Abstract submissions that do not conform to the guidelines will not be accepted
  • Abstract submissions received after the given deadline, due to any reason will not be accepted unless the deadline is extended
  • The abstract should be submitted in the format of an MS Word (.doc or .docx) document
  • The deadline to submit your abstract is August 23rd, 2024.

The basic format for abstract

  • The word limit for abstracts is 275 words
  • Keywords should be provided as a must (no more than 6 words)
  • Keywords should be written in lowercase letters (Not applicable to names/scientific names) and should be separated with commas
  • Please do not include subheadings, bullets, lists and header/footer in the abstract
  • Abstract titles should be short, but descriptive. Informative titles, indicating key points are encouraged. Abbreviations should not be used in the title
  • Acronyms should be written in full the first time, mentioned in the text, followed by the abbreviation in parentheses
  • When submitting your abstract, it is advised to adhere to the following structure: Introduction/Background, Methods, Results, Discussion, Conclusions, and/or Recommendations. However, this structure is not mandatory if it does not align with the nature of your abstract.

Abstract review process

Each abstract will be reviewed by at least 2 to 3 independent scientific reviewers according to the following six criteria:

  1. Relevance to the meeting objectives
  2. Background and rationale for the study/work
  3. Appropriateness of methods
  4. Presentation of results
  5. Conclusions and implication of results
  6. Public health significance

You will receive an email upon submission with a copy of the content that you submitted.

Disclaimer: Please note that the submission or submission confirmation via email does not mean that your submission is accepted. Our team will carefully review the abstract based on expertise and relevance for the meeting. Accepted abstracts will be notified by September 2nd, 2024.